DENISE RUSSELL: Open Payments
NPI 1972830909 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,082 in 114 payments from 21 companies in 2025. Trend: 2023 $2,482 · 2024 $1,798 · 2025 $2,082
Food & beverage: $2,082
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $276 |
| ABBVIE INC. | 22 | $274 |
| Eisai Inc. | 6 | $255 |
| PFIZER INC. | 10 | $193 |
| Novo Nordisk Inc | 11 | $144 |
| Lilly USA, LLC | 10 | $134 |
| Axsome Therapeutics, Inc. | 4 | $105 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| Dexcom, Inc. | 4 | $89 |
| Exact Sciences Corporation | 4 | $79 |
Products named: Leqembi, AIRSUPRA, FARXIGA, VRAYLAR, NURTEC ODT, REXULTI, Dexcom G6 Transmitter, UBRELVY.
Industry payments across TX — which companies pay providers there.
